mRNA readies for its second act: a vaccine for RSV, and then cancer
Scientists are adapting mRNA technology used for COVID-19 vaccinations to combat deadly illnesses, including cancer.
Stay updated with breaking news from Collaborating Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists are adapting mRNA technology used for COVID-19 vaccinations to combat deadly illnesses, including cancer.
Europe is experiencing an increasingly large circulation of influenza and the respiratory syncytial virus (RSV).
Now available! 'Tamsang-Tamsong On-Demand Delivery' platform, a business model based on Social Solidarity Economy idea by a Chula researcher that supports community ownership and synergies, creates jobs, generates revenue, and reduces consumer costs. BANGKOK, Dec. 22, 2022 /PRNewswire/ -- In the delivery business, riders are underpaid while their working conditions are risky with low social security, while consumers are paying more for what they believe is the "best value," suggests Akkanut Wantanasombat, a researcher from the Institute for Asian Studies, ChulalongkornUnivers...
To improve medical product safety for all, report suspected side effects and adverse incidents as part of the #MedSafetyWeek global campaign
China and India have approved nasal vaccines for use as a booster dose, but the availability of nasal vaccines in the United States and Europe may be years away.